View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
January 27, 2022

Clarify Health unveils cloud software to improve clinical trial diversity

The analytics of the software is based on a dataset that comprises SDoH data at the patient level for a variety of aspects

Clarify Health has launched the real-world evidence-based cloud software, Clarify Trials, designed to aid life sciences companies to enhance the recruitment of clinical trial subjects from diverse and underrepresented communities.

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

The software offers more than 400 social determinants of health (SDoH) insights to help research sites as well as investigators to enrol patients from diverse populations into the trials.

It also helps in evaluating the referral patterns of doctors to facilitate coordinated outreach within underserved people. 

Furthermore, it allows life sciences companies and clinical research organisations to lower health inequalities without unwarranted delays in the trial, budget overruns, or change in protocol, while they navigate the 2020 guidance of the Food and Drug Administration to boost trial diversity.

The analytics of the software is based on a dataset that comprises SDoH data at the patient level for a variety of aspects, including race, gender, level of income, ethnicity, access to transportation, stability in housing, education level and health literacy.

More than 300 million patient lives are covered by these data, which are connected to government and commercial claims, prescription, clinical and dispensing information. 

Life sciences firms could assess disparities in health within different patient groups and enrol people who best represent the future patient population of their treatment.

Clarify Health CEO Jean Drouin said: “Greater clinical trial diversity has an important role to play in tackling undeniable disparities in healthcare. 

“Clarify’s patient journey analytics deliver socio-behavioural insights to ensure the people most in need are included in clinical research, accurately diagnosed and prescribed the right therapy.”

The cloud-based business applications of the company leverage the Clarify Atlas Platform that charts more than 300 million patient journeys to provide over 18 billion artificial intelligence-driven predictions and surface insights quickly and accurately. 

Related Companies

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU